Dr. Constantine George Fisher, MD

Dr. Fisher practices at NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital.

Dr. Fisher's NPI, 1073878054, was assigned on July 6, 2012. Dr. Fisher graduated from CUNY School of Medicine in 2012. Dr. Fisher holds New York license 281016.

Dr. Fisher's primary practice is NewYork-Presbyterian Queens, at 56-45 Main Street, Flushing, NY 11355 in Queens County. The practice phone is (718) 670-2000.

Dr. Fisher's primary practice is NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Fisher to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fisher practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Fisher's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Fisher is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Fisher is licensed in New York.

Dmand AI lists acid reflux, acute gastroduodenitis, cirrhosis of the liver, colonoscopy, gastrointestinal bleeding, hemorrhoids, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Fisher treats.

CMS data shows 1,300 Medicare services from Dr. Fisher across 20 procedure codes in 2024, for 495 Medicare patients. Medicare paid $113,714 for them.

CMS counts 495 Medicare patients who saw Dr. Fisher in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fisher's median patient age at 68, with 48% women.

In 2024, Dr. Fisher wrote 348 Medicare Part D claims for 161 patients. 80% of them were for generic drugs. CMS names the drug for 228 of them, across 6 drugs with 11 or more claims each, at $59,724 in total drug cost. In 2023, CMS named 235 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fisher for performance year 2024, reported through an alternative payment model (APM). Dr. Fisher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 291 procedures of colonoscopy by Dr. Fisher, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Fisher, published from 2017 to 2024. 2017 was the busiest year, with 2. Dr. Fisher has published most often in ACG Case Rep J. Dr. Fisher's most frequent co-authors are Samson B. Ferm, MD, Syed Ahsan Hussain, MD and Sang Hoon Kim, MD.

CMS Open Payments shows 292 general payments to Dr. Fisher from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Phathom Pharmaceuticals, Inc. paid the most, $12,276.

Dmand AI lists 2 awards for Dr. Fisher, most recently Evelyn and Thomas DeCoursey Chief Fellow of Gastroenterology in 2018.

Dr. Fisher graduated from CUNY School of Medicine in 2012. Dr. Fisher is a member of ACG and ASGE.

Dr. Fisher is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.